<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39543596</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1741-7015</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>14</Day></PubDate></JournalIssue><Title>BMC medicine</Title><ISOAbbreviation>BMC Med</ISOAbbreviation></Journal><ArticleTitle>Symptom profile, case and symptom clustering, clinical and demographic characteristics of a multicentre cohort of 1297 patients evaluated for Long-COVID.</ArticleTitle><Pagination><StartPage>532</StartPage><MedlinePgn>532</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">532</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12916-024-03746-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Long-COVID symptoms remain incompletely defined due to a large heterogeneity in the populations studied, case definitions, and settings of care. The aim of this study was to assess, in patients accessing care for Long-COVID, the profile of symptoms reported, the possible clustering of symptoms and cases, the functional status compared to pre-infection, and the impact on working activity.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Multicentre cohort study with a collection of both retrospective and prospective data. Demographics, comorbidities, severity and timing of acute COVID, subjective functional status, working activity and presence of 30 different symptoms were collected using a shortened version of the WHO Post COVID-19 Case Report Form. The impact on working activity was assessed in multivariable logistic regression models. Clustering of symptoms was analysed by hierarchical clustering and the clustering of cases by two-step automatic clustering.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The study evaluated 1297 individuals (51.5% women) from 30 clinical centres. Men and women had different profiles in terms of comorbidities, vaccination status, severity and timing of acute SARS-CoV-2 infection. Fatigue (55.9%) and dyspnea (47.2%) were the most frequent symptoms. Women reported more symptoms (3.6 vs. 3.1, p&#x2009;&lt;&#x2009;0.001), with a significantly higher prevalence of memory loss, difficult concentration, cough, palpitation or tachycardia, dermatological abnormalities, brain fog, headache and visual disturbances. Dyspnea was more common in men. In the cluster analysis of the 19 more common symptoms, five aggregations were found: four two-symptom clusters (smell and taste reduction; anxiety and depressed mood; joint pain or swelling and muscle pain; difficult concentration and memory loss) and one six-symptom cluster (brain fog, equilibrium/gait disturbances, headache, paresthesia, thoracic pain, and palpitations/tachycardia). In a multivariable analysis, headache, dyspnea, difficult concentration, disturbances of equilibrium or gait, visual disturbances and muscular pain were associated with reduced or interrupted working activity. Clustering of cases defined two clusters, with distinct characteristics in terms of phase and severity of acute infection, age, sex, number of comorbidities and symptom profile.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The findings provide further evidence that Long-COVID is a heterogeneous disease with manifestations that differ by sex, phase of the pandemic and severity of acute disease, and support the possibility that multiple pathways lead to different clinical manifestations.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Floridia</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3971-0141</Identifier><AffiliationInfo><Affiliation>National Center for Global Health, Istituto Superiore Di Sanit&#xe0;, Rome, Italy. marco.floridia@iss.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giuliano</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Center for Global Health, Istituto Superiore Di Sanit&#xe0;, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weimer</LastName><ForeName>Liliana Elena</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>National Center for Global Health, Istituto Superiore Di Sanit&#xe0;, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciardi</LastName><ForeName>Maria Rosa</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agostoni</LastName><ForeName>Piergiuseppe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centro Cardiologico Monzino, IRCCS, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Science and Community Medicine, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palange</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rovere Querini</LastName><ForeName>Patrizia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>IRCCS Ospedale S. Raffaele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zucco</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Infectious Disaese Unit, Ospedale Amedeo Di Savoia, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tosato</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lo Forte</LastName><ForeName>Aldo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Multidimensional Medicine, Internal Medicine Unit, San Giovanni Di Dio Hospital, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonfanti</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Fondazione IRCCS San Gerardo Dei Tintori, Monza, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Milano-Bicocca, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lacedonia</LastName><ForeName>Donato</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barisione</LastName><ForeName>Emanuela</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Figliozzi</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andreozzi</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Predictive Medicine Unit, Department of Internal Medicine, Endocrine-Metabolic Sciences and Infectious Diseases, Azienda Ospedaliero Universitaria Policlinico Umberto I, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Damiano</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular, Endocrine-Metabolic Diseases and Ageing, Istituto Superiore Di Sanit&#xe0;, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pricci</LastName><ForeName>Flavia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular, Endocrine-Metabolic Diseases and Ageing, Istituto Superiore Di Sanit&#xe0;, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onder</LastName><ForeName>Graziano</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Office of the President, Istituto Superiore Di Sanit&#xe0;, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>I. S. S. Long-COVID Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med</MedlineTA><NlmUniqueID>101190723</NlmUniqueID><ISSNLinking>1741-7015</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Dyspnea</Keyword><Keyword MajorTopicYN="N">Fatigue</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Post-COVID</Keyword><Keyword MajorTopicYN="N">Symptom clusters</Keyword><Keyword MajorTopicYN="N">Symptoms</Keyword></KeywordList><CoiStatement><b>Declarations</b> <b>Ethics approval and consent to participate</b> The Italian National Ethics Committee approved the project (AOO-ISS&#x2014;19/04/2022&#x2013;0015066 Class: PRE BIO CE 01.00). Written informed consent was required for patient inclusion, using a patient information and consent form also approved by the Italian National Ethics Committee. <b>Consent for publication</b> Not applicable. <b>Competing interests</b> The authors declare no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Grisetti</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grassi</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tiple</LastName><ForeName>Dorina</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Villa</LastName><ForeName>Marika</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Polizzi</LastName><ForeName>Cosimo</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Galati</LastName><ForeName>Fabio</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pasculli</LastName><ForeName>Patrizia</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Colazzo</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mattavelli</LastName><ForeName>Irene</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salvioni</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pellegrino</LastName><ForeName>Daniela</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bezzio</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Olmati</LastName><ForeName>Federica</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sanna</LastName><ForeName>Arianna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schifano</LastName><ForeName>Arianna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Angelone</LastName><ForeName>Dario</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fabozzi</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Santoro</LastName><ForeName>Simona</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fumagalli</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Merolla</LastName><ForeName>Aurora</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Canti</LastName><ForeName>Valentina</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ruggiero</LastName><ForeName>Maria Pia</ForeName><Initials>MP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Messina</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Biganzoli</LastName><ForeName>Marina</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buonsenso</LastName><ForeName>Danilo</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ianniello</LastName><ForeName>Alice</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Galluzzo</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Macculi</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bottaro</LastName><ForeName>Valeria Maria</ForeName><Initials>VM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bonaffini</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Spolti</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Squillace</LastName><ForeName>Nicola</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Campanino</LastName><ForeName>Terence</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alo&#xe8;</LastName><ForeName>Teresita</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tagliabue</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Testerini</LastName><ForeName>Federica</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miglionico</LastName><ForeName>Marzia</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barbitta</LastName><ForeName>Antonia</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cenciarelli</LastName><ForeName>Chiara</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pagnanelli</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Piccinni</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gnerre</LastName><ForeName>Paola</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parodi</LastName><ForeName>Lionello</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Monaco</LastName><ForeName>Eugenia</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buscaglia</LastName><ForeName>Sandra</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Visconti</LastName><ForeName>Antonella</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Loso</LastName><ForeName>Kwelusukila</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martino</LastName><ForeName>Giuseppe Pio</ForeName><Initials>GP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bitti</LastName><ForeName>Giuseppina</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Postacchini</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cognigni</LastName><ForeName>Antonella</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>di Rosolini</LastName><ForeName>Maria Antonietta</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mavilla</LastName><ForeName>Sergio</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Toraldo</LastName><ForeName>Domenico Maurizio</ForeName><Initials>DM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vagheggini</LastName><ForeName>Guido</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bardi</LastName><ForeName>Giulio</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Levantino</LastName><ForeName>Giuseppa</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stefan</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parati</LastName><ForeName>Gianfranco</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perger</LastName><ForeName>Elisa</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gianfranceschi</LastName><ForeName>Enrico</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pozzoli</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Leo</LastName><ForeName>Pasqualina</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grignolo</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Monari</LastName><ForeName>Caterina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bianchi</LastName><ForeName>Leila</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Galli</LastName><ForeName>Luisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Surace</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Falbo</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boni</LastName><ForeName>Silvia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Battello</LastName><ForeName>Claudia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baghiris</LastName><ForeName>Caterina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Serviddio</LastName><ForeName>Gaetano</ForeName><Initials>G</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>16</Day><Hour>9</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>15</Day><Hour>0</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39543596</ArticleId><ArticleId IdType="pmc">PMC11566432</ArticleId><ArticleId IdType="doi">10.1186/s12916-024-03746-9</ArticleId><ArticleId IdType="pii">10.1186/s12916-024-03746-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization (WHO). COVID-19 epidemiological update. Edition 167, 17 May 2024. Available at: https://www.who.int/publications/m/item/covid-19-epidemiological-update-edition-167. Accessed 27 May 2024.</Citation></Reference><Reference><Citation>Calvo Ramos S, Maldonado JE, Vandeplas A, V&#xe1;nyol&#xf3;s I, European Commission Directorate-general for economic and financial affairs. Long COVID: a tentative assessment of its impact on labour market participation and potential economic effects in the EU.</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE). NICE Guideline, No. 188, 2020 Dec 18: COVID-19 rapid guideline: managing the long-term effects of COVID-19.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Diseases Control and Prevention (CDC). Long COVID or Post-COVID Conditions. Updated Mar. 14, 2024. Available at: https://www.covid.gov/be-informed/longcovid/about#term. Accessed 27 May 2024.</Citation></Reference><Reference><Citation>World Health Organization (WHO). Post COVID-19 condition (Long COVID). 7 December 2022. Available at: https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition. Accessed 27 May 2024.</Citation></Reference><Reference><Citation>European Center for Disease prevention and Control (ECDC) . Prevalence of post COVID-19 condition symptoms: a systematic review and meta-analysis of cohort study data, stratified by recruitment setting. 27 October 2022. Available at: https://www.ecdc.europa.eu/sites/default/files/documents/Prevalence-post-COVID-19-condition-symptoms.pdf. Accessed 27 May 2024.</Citation></Reference><Reference><Citation>Cogliandro V, Bonfanti P. Long COVID: lights and shadows on the clinical characterization of this emerging pathology. New Microbiol. 2024;47:15&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">38700879</ArticleId></ArticleIdList></Reference><Reference><Citation>Hua MJ, Butera G, Akinyemi O, Porterfield D. Biases and limitations in observational studies of long COVID prevalence and risk factors: a rapid systematic umbrella review. PLoS ONE. 2024;19:e0302408. 10.1371/journal.pone.0302408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11065234</ArticleId><ArticleId IdType="pubmed">38696415</ArticleId></ArticleIdList></Reference><Reference><Citation>Italian National Centre for Disease Prevention and Control (Centro Nazionale per la Prevenzione ed il Controllo delle Malattie). CCM Program 2021. Available at: https://www.ccm-network.it/pagina.jsp?id=node/2438. Accessed 18 June 2024.</Citation></Reference><Reference><Citation>Floridia M, Grassi T, Giuliano M, Tiple D, Pricci F, Villa M, Silenzi A, Onder G. Characteristics of Long-COVID care centers in Italy. A national survey of 124 clinical sites. Front Public Health. 2022;10:975527.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9437305</ArticleId><ArticleId IdType="pubmed">36062113</ArticleId></ArticleIdList></Reference><Reference><Citation>Post COVID-19 CRF from the WHO Global Clinical Platform for COVID-19. Available at: https://www.who.int/publications/i/item/global-covid-19-clinical-platform-case-report-form-(crf)-for-post-covid-conditions-(post-covid-19-crf-). Accessed 27 May 2024.</Citation></Reference><Reference><Citation>Castriotta L, Onder G, Rosolen V, Beorchia Y, Fanizza C, Bellini B, et al. Examining potential Long COVID effects through utilization of healthcare resources: a retrospective, population-based, matched cohort study comparing individuals with and without prior SARS-CoV-2 infection. Eur J Public Health. 2024;18:ckae001. 10.1093/eurpub/ckae001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11161167</ArticleId><ArticleId IdType="pubmed">38243748</ArticleId></ArticleIdList></Reference><Reference><Citation>Uemura K, Kanata T, Ono S, Michihata N, Yasunaga H. The disease severity of COVID-19 caused by Omicron variants: a brief review. Ann Clin Epidemiol. 2023;5:31&#x2013;6. 10.37737/ace.23005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10944996</ArticleId><ArticleId IdType="pubmed">38505732</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Mart&#xed;n-Guerrero JD, Pellicer-Valero &#xd3;J, Navarro-Pardo E, G&#xf3;mez-Mayordomo V, Cuadrado ML, et al. Female sex is a risk factor associated with long-term post-COVID related-symptoms but not with COVID-19 symptoms: the&#xa0;long-covid-exp-cm&#xa0;multicenter&#xa0;Study. J Clin Med. 2022;11:413. 10.3390/jcm11020413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, et al. Risk factors associated with post-COVID-19 condition: a systematic review and meta-analysis. JAMA Intern Med. 2023;183:566&#x2013;80. 10.1001/jamainternmed.2023.0750.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Pillay J, Rahman S, Guitard S, Wingert A, Hartling L. Risk factors and preventive interventions for post&#xa0;Covid-19&#xa0;condition: systematic&#xa0;review. Emerg Microbes Infect. 2022;11(1):2762&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9665097</ArticleId><ArticleId IdType="pubmed">36302216</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Santillana M, Ognyanova K, Safarpour A, Lunz Trujillo K, Simonson MD, et al. Prevalence and correlates of long COVID symptoms among US adults. JAMA Netw Open. 2022;5(10):e2238804. 10.1001/jamanetworkopen.2022.38804.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>Erinoso O, Osibogun O, Balakrishnan S, et al. Long COVID among US adults from a population-based study: Association with vaccination, cigarette smoking, and the modifying effect of chronic obstructive pulmonary disease (COPD). Prev Med. 2024;184:108004. 10.1016/j.ypmed.2024.108004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11148848</ArticleId><ArticleId IdType="pubmed">38754738</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G, McCann K, O&#x2019;Brien C, Savinelli S, Tinago W, Yousif O, et al. Identification of distinct long COVID clinical phenotypes through&#xa0;cluster&#xa0;analysis&#xa0;of self-reported symptoms. Open Forum Infect Dis. 2022;9:ofac060. 10.1093/ofid/ofac060.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8900926</ArticleId><ArticleId IdType="pubmed">35265728</ArticleId></ArticleIdList></Reference><Reference><Citation>Stalker G, Tudas R, Garg A, Graham L, Thurman AL, Wiblin RT, et al. Long-COVID&#xa0;improves in 50% of patients after a year in a Midwestern cohort. medRxiv [Preprint]. 2024 May 1:2024.04.30.24306497. 10.1101/2024.04.30.24306497.</Citation></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133&#x2013;46. 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Houdt SCM, Slurink IAL, Mertens G. Long COVID is not a uniform syndrome: Evidence from person-level symptom clusters using latent class analysis. J Infect Public Health. 2024;17:321&#x2013;8. 10.1016/j.jiph.2023.12.019.</Citation><ArticleIdList><ArticleId IdType="pubmed">38183882</ArticleId></ArticleIdList></Reference><Reference><Citation>Agostoni P, Mapelli M, Salvioni E, Mattavelli I, Banfi C, Bonomi A, et al. Symptomatic post COVID patients have impaired alveolar capillary membrane function and high VE/VCO2. Respir Res. 2024;25:82. 10.1186/s12931-023-02602-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10851544</ArticleId><ArticleId IdType="pubmed">38331869</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello-Chavolla OY, Ferm&#xed;n-Mart&#xed;nez CA, Ram&#xed;rez-Garc&#xed;a D, Vargas-V&#xe1;zquez A, Fern&#xe1;ndez-Chirino L, Basile-Alvarez MR, et al. Prevalence and determinants of post-acute sequelae after SARS-CoV-2 infection (Long COVID) among adults in Mexico during 2022: a retrospective analysis of nationally representative data. Lancet Reg Health Am. 2024;30:100688. 10.1016/j.lana.2024.100688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10847769</ArticleId><ArticleId IdType="pubmed">38327277</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentilotti E, G&#xf3;rska A, Tami A, Gusinow R, Mirandola M, Rodr&#xed;guez Ba&#xf1;o J, et al. Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort. EClinicalMedicine. 2023;62:102107. 10.1016/j.eclinm.2023.102107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10466236</ArticleId><ArticleId IdType="pubmed">37654668</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha C, Baek G. Symptoms and management of long COVID: a scoping review. J Clin Nurs. 2024;33:11&#x2013;28. 10.1111/jocn.16150.</Citation><ArticleIdList><ArticleId IdType="pubmed">34913540</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Duarte &#xc1;, Rivera-Izquierdo M, Guerrero-Fern&#xe1;ndez de Alba I, P&#xe9;rez-Contreras M, Fern&#xe1;ndez-Mart&#xed;nez NF, Ruiz-Montero R, et al. Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study. BMC Med. 2021;19:129. 10.1186/s12916-021-02003-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8134820</ArticleId><ArticleId IdType="pubmed">34011359</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlile O, Briggs A, Henderson AD, Butler-Cole BFC, Tazare J, Tomlinson LA, et al. Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT). Lancet Reg Health Eur. 2024;40:100908. 10.1016/j.lanepe.2024.100908.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11059448</ArticleId><ArticleId IdType="pubmed">38689605</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallin E, Lipcsey M, Frithiof R, Hultstr&#xf6;m M, Larsson IM. Occurrence of Return to Work at 12 Months Among Patients with Covid-19 Cared for in Intensive Care. A prospective, Longitudinal Study. Available at SSRN:&#xa0;https://ssrn.com/abstract=4830002&#xa0;or&#xa0;10.2139/ssrn.4830002.</Citation><ArticleIdList><ArticleId IdType="pubmed">39178644</ArticleId></ArticleIdList></Reference><Reference><Citation>Reese JT, Blau H, Casiraghi E, Bergquist T, Loomba JJ, Callahan TJ, et al. Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes. EBioMedicine. 2023;87:104413. 10.1016/j.ebiom.2022.104413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9769411</ArticleId><ArticleId IdType="pubmed">36563487</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Zang C, Xu Z, Zhang Y, Xu J, Bian J, et al. Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes. Nat Med. 2023;29:226&#x2013;35. 10.1038/s41591-022-02116-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9873564</ArticleId><ArticleId IdType="pubmed">36456834</ArticleId></ArticleIdList></Reference><Reference><Citation>Man MA, Rosca D, Bratosin F, Fira-Mladinescu O, Ilie AC, Burtic SR, et al. Impact of pre-infection COVID-19 vaccination on the incidence and severity of post-COVID syndrome: a systematic review and meta-analysis. Vaccines (Basel). 2024;12:189. 10.3390/vaccines12020189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10893048</ArticleId><ArticleId IdType="pubmed">38400172</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>